Skip to main content

Animations

MJFF Publications

581 - 590 of 6078 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • OPEN
    Title: Fusion of biomedical imaging studies for increased sample size and diversity: a case study of brain MRI
    Journal Name: Frontiers in Radiology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fradi.2024.1283392
    Citation Count: 0
  • OPEN
    Title: Transcriptomics of Human Brain Tissue in Parkinson’s Disease: a Comparison of Bulk and Single-cell RNA Sequencing
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s12035-024-04124-5
    Best OA location URL:
    Citation Count: 2
  • OPEN
    Title: Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials Initiative
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-230363
    Best OA location URL:
    Citation Count: 1
  • OPEN
    Title: Cryogel microcarriers for sustained local delivery of growth factors to the brain
    Journal Name: Journal of Controlled Release
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jconrel.2024.03.023
    Citation Count: 4
  • OPEN
    Title: Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06534-8
    Best OA location URL:
    Citation Count: 3
  • OPEN
    Title: Orthogonal analysis of mitochondrial function in Parkinson’s disease patients
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06617-6
    Citation Count: 3
  • OPEN
    Title: RedOx regulation of LRRK2 kinase activity by active site cysteines
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00683-5
    Best OA location URL:
    Citation Count: 3
  • OPEN
    Title: Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.26923
    Citation Count: 9
  • OPEN
    Title: DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease
    Journal Name: GeroScience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11357-024-01116-0
    Citation Count: 10
  • OPEN
    Title: Identification and structural characterization of small molecule inhibitors of PINK1
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-58285-3
    Best OA location URL:
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.